Blog
RSS FeedPosted by Michael Wonder on 31 Oct 2023
PBS listing expanded to include treatment resistant high frequency episodic migraine
31 October 2023 - From 1 November 2023, Australians with treatment resistant high frequency episodic migraine will have access to fremanezumab ...
Posted by Michael Wonder on 30 Oct 2023
Expanded access to chronic heart failure treatment on the PBS
30 October 2023 - More Australians with chronic heart failure will have access to subsidised treatment under the PBS. ...
Posted by Michael Wonder on 29 Oct 2023
100,000 patients eligible for heart drug under PBS
28 October 2023 - Almost 100,000 patients are set to save hundreds of dollars per year as access to a ...
Posted by Michael Wonder on 16 Oct 2023
Cheaper medicines for cervical cancer, urotherial cancer and spinal muscular atrophy
16 October 2023 - From 1 October 2023, Australians with cervical cancer, urothelial cancer and spinal muscular atrophy will have access ...
Posted by Michael Wonder on 30 Sep 2023
Schedule of Pharmaceutical Benefits - 1 October 2023
1 October 2023 - The October 2023 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...
Posted by Michael Wonder on 31 Aug 2023
Schedule of Pharmaceutical Benefits - 1 September 2023
1 September 2023 - The September 2023 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...
Posted by Michael Wonder on 15 Aug 2023
New treatments for people with chronic migraine and soft tissue sarcoma added to the PBS
14 August 2023 - From August 2023, Australians with chronic migraine and soft tissue sarcoma will have access to new ...
Posted by Michael Wonder on 02 Jul 2023
Widened eligibility for oral antiviral Paxlovid, plus new medicines on PBS
2 July 2023 - From 1 July 2023, Australians with severe thrombocytopenia and diabetic kidney disease will have access to ...
Posted by Michael Wonder on 01 Jul 2023
Schedule of Pharmaceutical Benefits - 1 July 2023
1 July 2023 - The July 2023 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...
Posted by Michael Wonder on 01 Jul 2023
Changes to the National Immunisation Program effective 1 July 2023
30 June 2023 - From 1 July 2023, Vaxelis will be added to the National Immunisation Program as an alternative ...
Posted by Michael Wonder on 05 Jun 2023
New treatments for Australians with endometrial cancer and Lennox-Gastaut syndrome
5 June 2023 - From 1 June 2023, Australians with endometrial cancer and Lennox-Gastaut syndrome will have access to new ...
Posted by Michael Wonder on 01 Jun 2023
Antengene announces Xpovio plus bortezomib and dexamethasone included for reimbursement by the PBS in Australia for the treatment of relapsed and/or refractory multiple myeloma
31 May 2023 - This inclusion by the PBS for the treatment of patients with relapsed and/or refractory multiple myeloma who ...
Posted by Michael Wonder on 31 May 2023
Schedule of Pharmaceutical Benefits - 1 June 2023
1 June 2023 - The June 2023 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...
Posted by Michael Wonder on 30 Apr 2023
Schedule of Pharmaceutical Benefits - 1 May 2023
1 May 2023 - The May 2023 issue of the Schedule of Pharmaceutical Benefits is out and now in effect. ...
Posted by Michael Wonder on 21 Apr 2023
Publication of stage 1 and stage 2 PBS process improvements metrics report (2021-22)
21 April 2023 - The 2021-22 Stage 1 and Stage 2 PBS process improvements metrics report is now available. ...